entertainment -WSS

entertainment

author：entertainment 2025-10-03 00:07:54 - browse：6

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Wikipedia

WSS

Today's health inequities arise from racist U.S. history, say experts

Eli Lilly’s Mounjaro succeeds in second weight

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Novo pauses ads for weight loss drug Wegovy amid demand

explore

entertainment

leisure time

Alkermes shareholders re

Senate panel passes drug pricing bills, but drops one PBM reform

United colonoscopy coverage change 'may cost lives,' doctors say

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Psychedelics group wrestles with new pharma identity

Senate panel passes drug pricing bills, but drops one PBM reform

Virginia high school admissions case could be legal follow

Ventyx halts psoriasis drug development after lackluster trial results

hotspot

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Xenotransplantation trials will require adjusting expectations, experts say

Bispecific antibodies are next new thing in cancer immunotherapy

Living organ donors deserve priority status for transplants

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Wikipedia

focus

hotspot

knowledge